InvestSMART

ORDINARY FULLY PAID (ASX: OPT) - Announcements

DELISTED - Current share price for OPT : $0.013

ASX company news and announcements for ORDINARY FULLY PAID (OPT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ORDINARY FULLY PAID (OPT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ORDINARY FULLY PAID (OPT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ORDINARY FULLY PAID (OPT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 S&P DJI Announces March 2019 Quarterly Rebalance 8 Mar 2019 8:22AM $0.780 $0.013 fallen by 98.33%
$18 Opthea Ph2b Trial Advances With 2nd Positive Safety Review 7 Mar 2019 9:26AM $0.760 $0.013 fallen by 98.29%
$18 Opthea Half Year Report and Accounts 25 Feb 2019 9:06AM $0.720 $0.013 fallen by 98.19%
$18 Opthea Granted Japanese Patent Covering OPT-302 29 Jan 2019 9:02AM $0.780 $0.013 fallen by 98.33%
$18 Becoming a substantial holder 4 Dec 2018 3:42PM $0.570 $0.013 fallen by 97.72%
$18 Becoming a substantial holder 4 Dec 2018 1:38PM $0.560 $0.013 fallen by 97.68%
$18 Change of Director's Interest Notice - GK 30 Nov 2018 4:09PM $0.560 $0.013 fallen by 97.68%
$18 Change of Director's Interest Notice - MB 30 Nov 2018 4:07PM $0.560 $0.013 fallen by 97.68%
$18 Appendix 3B 30 Nov 2018 4:05PM $0.560 $0.013 fallen by 97.68%
$18 Change in substantial holding 30 Nov 2018 10:13AM $0.570 $0.013 fallen by 97.72%
$18 Results of Meeting 29 Nov 2018 2:46PM $0.570 $0.013 fallen by 97.72%
$18 Opthea CEO Presentation to the 2018 AGM 29 Nov 2018 9:41AM $0.570 $0.013 fallen by 97.72%
$18 Opthea Chairman Address to the 2018 AGM 29 Nov 2018 9:39AM $0.570 $0.013 fallen by 97.72%
$18 Appendix 3B 28 Nov 2018 9:38AM $0.580 $0.013 fallen by 97.76%
$18 Opthea Options Exercise Generates Proceeds of A$13.3m 28 Nov 2018 9:36AM $0.580 $0.013 fallen by 97.76%
$18 Opthea confirms final patient enrolment in Ph2b wAMD trial 26 Nov 2018 8:50AM $0.580 $0.013 fallen by 97.76%
$18 Appendix 3B 21 Nov 2018 8:50AM $0.570 $0.013 fallen by 97.72%
$18 Appendix 3B 16 Nov 2018 9:49AM $0.580 $0.013 fallen by 97.76%
$18 Change in substantial holding 15 Nov 2018 8:34AM $0.570 $0.013 fallen by 97.72%
$18 Opthea Phase 2b wAMD trial fully recruited ahead of schedule 14 Nov 2018 8:59AM $0.570 $0.013 fallen by 97.72%
$18 Appendix 3B 12 Nov 2018 8:54AM $0.570 $0.013 fallen by 97.72%
$18 Appendix 3B 9 Nov 2018 9:26AM $0.565 $0.013 fallen by 97.70%
$18 Change in substantial holding 9 Nov 2018 8:52AM $0.565 $0.013 fallen by 97.70%
$18 Appendix 3B 2 Nov 2018 8:54AM $0.580 $0.013 fallen by 97.76%
$18 Opthea Receives A$12m R&D Tax Incentive 31 Oct 2018 8:52AM $0.590 $0.013 fallen by 97.80%

601 - 625 of 733 results

Page 25 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.